Overview

Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the biological effects in the primary tumor following a short, pre-operative course of treatment with PF-00298804 in patients with Oral Cavity Cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Pfizer